FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111036608> ?p ?o ?g. }

• W3111036608 endingPage "734" @default.
• W3111036608 startingPage "725" @default.
• W3111036608 abstract "Abstract Background and objectives Anti‐CD38 monoclonal antibodies, including daratumumab and isatuximab, often interfere with pretransfusion testing. Dithiothreitol (DTT) treatment of red blood cells (RBCs) negates this interference. However, the optimum DTT concentration and treatment time have not been well defined. Here, we quantified CD38 on RBCs before and after DTT treatment using a flow cytometric antibody binding assay (FABA) to specify the optimum conditions for CD38 inactivation. Materials and methods For FABA, untreated or DTT‐treated RBCs were incubated with fluorescein isothiocyanate‐labelled anti‐CD38 antibody, in the presence or absence of 100‐fold or more excess of unlabelled anti‐CD38 antibody, and then analysed by flow cytometry (FCM). Dissociation of CD38‐positive and control histograms was determined from the D‐value using the Kolmogorov–Smirnov test. The results from FABA were compared with those from conventional FCM, indirect antiglobulin test (IAT) and Western blotting. Results The results from FABA were more consistent than those from conventional FCM. The D‐value was found to be reliable in the analysis of difference between CD38 before and after DTT treatment. Our data showed that 0·0075 mol/l DTT for 30 min is sufficient to inactivate CD38 on RBCs. These results were stable and consistent with the findings from IAT. Conclusion Flow cytometric antibody binding assay is an objective way of evaluating the efficacy of DTT treatment for CD38 on RBCs. This approach allows the detection of a small number of cell surface antigens and will be useful for assessing the various chemical treatments to denature RBC antigens." @default.
• W3111036608 created "2020-12-21" @default.
• W3111036608 creator A5004197195 @default.
• W3111036608 creator A5007276495 @default.
• W3111036608 creator A5010777819 @default.
• W3111036608 creator A5012824176 @default.
• W3111036608 creator A5012940591 @default.
• W3111036608 creator A5016921453 @default.
• W3111036608 creator A5028434074 @default.
• W3111036608 creator A5031255027 @default.
• W3111036608 creator A5032340450 @default.
• W3111036608 creator A5034604621 @default.
• W3111036608 creator A5037162590 @default.
• W3111036608 creator A5041702299 @default.
• W3111036608 creator A5050349337 @default.
• W3111036608 creator A5065901351 @default.
• W3111036608 date "2020-12-13" @default.
• W3111036608 modified "2023-10-18" @default.
• W3111036608 title "A newly devised flow cytometric antibody binding assay helps evaluation of dithiothreitol treatment for the inactivation of CD38 on red blood cells" @default.
• W3111036608 cites W1551622384 @default.
• W3111036608 cites W1575893280 @default.
• W3111036608 cites W1641657728 @default.
• W3111036608 cites W1706622670 @default.
• W3111036608 cites W1852491924 @default.
• W3111036608 cites W1855126786 @default.
• W3111036608 cites W1984686364 @default.
• W3111036608 cites W2001372244 @default.
• W3111036608 cites W2001373658 @default.
• W3111036608 cites W2011634656 @default.
• W3111036608 cites W2034333141 @default.
• W3111036608 cites W2041337103 @default.
• W3111036608 cites W2100608745 @default.
• W3111036608 cites W2102942531 @default.
• W3111036608 cites W2128396804 @default.
• W3111036608 cites W2154379810 @default.
• W3111036608 cites W2253038466 @default.
• W3111036608 cites W2264954986 @default.
• W3111036608 cites W2520324136 @default.
• W3111036608 cites W2767256995 @default.
• W3111036608 cites W2775001520 @default.
• W3111036608 cites W2790371331 @default.
• W3111036608 cites W2800090965 @default.
• W3111036608 cites W2802999916 @default.
• W3111036608 cites W2804200164 @default.
• W3111036608 cites W2883614091 @default.
• W3111036608 cites W2893844449 @default.
• W3111036608 cites W2907617162 @default.
• W3111036608 cites W2911162310 @default.
• W3111036608 cites W2988984460 @default.
• W3111036608 cites W2995945119 @default.
• W3111036608 cites W3009577881 @default.
• W3111036608 cites W3024658664 @default.
• W3111036608 cites W4211037848 @default.
• W3111036608 cites W4234971900 @default.
• W3111036608 doi "https://doi.org/10.1111/vox.13052" @default.
• W3111036608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33314130" @default.
• W3111036608 hasPublicationYear "2020" @default.
• W3111036608 type Work @default.
• W3111036608 sameAs 3111036608 @default.
• W3111036608 citedByCount "1" @default.
• W3111036608 countsByYear W31110366082021 @default.
• W3111036608 crossrefType "journal-article" @default.
• W3111036608 hasAuthorship W3111036608A5004197195 @default.
• W3111036608 hasAuthorship W3111036608A5007276495 @default.
• W3111036608 hasAuthorship W3111036608A5010777819 @default.
• W3111036608 hasAuthorship W3111036608A5012824176 @default.
• W3111036608 hasAuthorship W3111036608A5012940591 @default.
• W3111036608 hasAuthorship W3111036608A5016921453 @default.
• W3111036608 hasAuthorship W3111036608A5028434074 @default.
• W3111036608 hasAuthorship W3111036608A5031255027 @default.
• W3111036608 hasAuthorship W3111036608A5032340450 @default.
• W3111036608 hasAuthorship W3111036608A5034604621 @default.
• W3111036608 hasAuthorship W3111036608A5037162590 @default.
• W3111036608 hasAuthorship W3111036608A5041702299 @default.
• W3111036608 hasAuthorship W3111036608A5050349337 @default.
• W3111036608 hasAuthorship W3111036608A5065901351 @default.
• W3111036608 hasConcept C10205521 @default.
• W3111036608 hasConcept C121332964 @default.
• W3111036608 hasConcept C147483822 @default.
• W3111036608 hasConcept C153911025 @default.
• W3111036608 hasConcept C159654299 @default.
• W3111036608 hasConcept C159912055 @default.
• W3111036608 hasConcept C181199279 @default.
• W3111036608 hasConcept C185592680 @default.
• W3111036608 hasConcept C203014093 @default.
• W3111036608 hasConcept C2777019933 @default.
• W3111036608 hasConcept C2777824588 @default.
• W3111036608 hasConcept C2781119759 @default.
• W3111036608 hasConcept C28328180 @default.
• W3111036608 hasConcept C43617362 @default.
• W3111036608 hasConcept C542903549 @default.
• W3111036608 hasConcept C54355233 @default.
• W3111036608 hasConcept C553184892 @default.
• W3111036608 hasConcept C55493867 @default.
• W3111036608 hasConcept C62520636 @default.
• W3111036608 hasConcept C86803240 @default.
• W3111036608 hasConcept C91881484 @default.
• W3111036608 hasConceptScore W3111036608C10205521 @default.

• next